Synopsys (NASDAQ:SNPS – Get Free Report) will issue its quarterly earnings data after the market closes on Wednesday, August 21st. Analysts expect the company to announce earnings of $3.28 per share for the quarter. Synopsys has set its FY 2024 guidance at 12.900-12.980 EPS and its Q3 2024 guidance at 3.250-3.300 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 22nd. The semiconductor company reported $3.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.03 by ($0.03). Synopsys had a net margin of 23.05% and a return on equity of 22.66%. The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the previous year, the company posted $1.76 EPS. The company’s revenue for the quarter was up 15.2% compared to the same quarter last year. On average, analysts expect Synopsys to post $10 EPS for the current fiscal year and $12 EPS for the next fiscal year.
Synopsys Trading Up 1.7 %
NASDAQ:SNPS opened at $558.22 on Tuesday. The firm has a fifty day simple moving average of $573.63 and a 200-day simple moving average of $566.64. Synopsys has a 12 month low of $427.63 and a 12 month high of $629.38. The company has a market capitalization of $85.53 billion, a P/E ratio of 60.68, a PEG ratio of 3.42 and a beta of 1.07.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on Synopsys
Insider Buying and Selling at Synopsys
In other Synopsys news, insider Geus Aart De sold 5,448 shares of the firm’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $620.95, for a total transaction of $3,382,935.60. Following the completion of the sale, the insider now owns 106,983 shares of the company’s stock, valued at $66,431,093.85. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Synopsys news, CEO Sassine Ghazi sold 10,294 shares of the company’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $582.41, for a total transaction of $5,995,328.54. Following the transaction, the chief executive officer now directly owns 62,568 shares in the company, valued at $36,440,228.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Geus Aart De sold 5,448 shares of Synopsys stock in a transaction on Monday, July 8th. The shares were sold at an average price of $620.95, for a total value of $3,382,935.60. Following the completion of the sale, the insider now directly owns 106,983 shares of the company’s stock, valued at $66,431,093.85. The disclosure for this sale can be found here. Insiders have sold 81,363 shares of company stock worth $49,361,263 in the last ninety days. 0.66% of the stock is owned by insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- What is a Dividend King?
- 2 Option Strategies to Maximize Profits in a Bear Market
- What is the Euro STOXX 50 Index?
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.